Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-17
2009-02-24
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235500, C514S253130, C514S318000, C514S343000, C514S355000, C514S356000, C540S597000, C544S124000, C544S365000, C546S194000, C546S279100, C546S316000, C546S321000
Reexamination Certificate
active
07494989
ABSTRACT:
Achiral pyrimidine derivatives and pyridine derivatives of the following formulae or analogs thereof have selective N-type calcium channel antagonistic activity and showed analgesic action when they were taken orally. They are useful as therapeutic agents for pains and various diseases associated with the N-type calcium channels.
REFERENCES:
patent: 4698340 (1987-10-01), Takaya et al.
patent: 6274588 (2001-08-01), Bös et al.
patent: 6350762 (2002-02-01), Niwa et al.
patent: 6350766 (2002-02-01), Uneyama et al.
patent: 6610717 (2003-08-01), Nakajo et al.
patent: 6855716 (2005-02-01), Ohno et al.
patent: 6995179 (2006-02-01), Uneyama et al.
patent: 7247645 (2007-07-01), Nakanishi et al.
patent: 2002/0002167 (2002-01-01), Niwa et al.
patent: 2005/0009814 (2005-01-01), Iwayama et al.
patent: 2-22266 (1990-01-01), None
patent: 98/49144 (1998-11-01), None
patent: 99/01438 (1999-01-01), None
patent: 00/78730 (2000-12-01), None
patent: WO 2004/080444 (2004-09-01), None
H. Takasugi et al, 1990, CAPLUS Abstract 113:40722.
M. Wallace, “Calcium and sodium channel antagonists for the treatment of pain”, Jun. 2000, PubMed Abstract,Clin. J. Pain., 16(2 Suppl.):S80-5.
J. Putney, Jr. et al, “Mechanisms of capacitative calcium entry”, 2001,Journal of Cell Science, 114 (12), pp. 2223-2229.
A. Damasio, “Alzheimer's Disease and Related Dementias”, 1996,Cecil Textbook of Medicine, 20thEd., vol. 2, pp. 1992-1996.
R. Layzer, “Section Five—Degenerative Diseases of the Nervous System”, 1996,Cecil Textbook of Medicine, 20thEd., vol. 2, pp. 2050-2057.
Fujita Shinichi
Hagihara Masako
Iwayama Satoshi
Koganei Hajime
Niwa Seiji
Ajinomoto Co. Inc.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Rao Deepak
LandOfFree
Pyridine compounds useful as N-type calcium channel antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine compounds useful as N-type calcium channel antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine compounds useful as N-type calcium channel antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4093099